InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Sofinnova Partners SAS. Director active across 1 company, notably CinCor Pharma, Inc.. Aggregated, 2 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €3.9m. Activity tracked since 15 August 2022. The latest transaction was filed on 15 August 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations